Poulvac Procerta HVT-IBD
turkey herpes virus, strain FC-126, expressing infectious bursal disease virus VP2 protein, live
Last updated:
MedicineVeterinaryAuthorised
MenQuadfi
meningococcal group A, C, W-135 and Y conjugate vaccine
Meningitis, Meningococcal
Date of authorisation:
Revision: 12
Last updated:
MedicineHumanAuthorised
EMEA-002754-PIP01-19 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Uro-nephrology
PIP number: P/0017/2021
Route(s) of administration: Oral use
Pharmaceutical form(s):
Capsule (hard)
Age appropriate oral formulation
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-002693-PIP01-19 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Infectious diseases
PIP number: P/0418/2020
Route(s) of administration: Oral use
Pharmaceutical form(s):
Tablet
Age-appropriate oral solid dosage form
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-003157-PIP01-21 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Uro-nephrology
PIP number: P/0431/2022
Route(s) of administration: Intravenous use
Pharmaceutical form(s):
Powder for solution for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-001666-PIP01-14-M01 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Uro-nephrology
PIP number: P/0171/2016
Route(s) of administration: Oral useGastric use
Pharmaceutical form(s):
Tablet
Age-appropriate oral liquid dosage form
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Briumvi
ublituximab
Multiple Sclerosis, Relapsing-Remitting
Multiple Sclerosis
Date of authorisation:
Revision: 5
Last updated:
MedicineHumanAuthorised
Tevimbra
tislelizumab
Esophageal Squamous Cell Carcinoma
Date of authorisation:
Revision: 3
Last updated:
MedicineHumanAuthorised